BIOMOLTHERA PHARMACEUTICAL CHEMISTRY Inc. was founded in 2024 at the Kütahya Dumlupınar Design Technology Development Zone to address the rapidly growing biomolecular therapeutics market in the pharmaceutical and chemical industries.
Our founder, Prof. Dr. Muharrem Akcan, has transferred his extensive academic and industrial expertise in peptide chemistry to Biomolthera, building the company on a solid scientific foundation. This strength has enabled Biomolthera to quickly emerge as an enterprise recognized for its innovative and high-impact R&D projects.
Core areas of expertise:
|
|
Biomolthera is committed to providing cutting-edge solutions in the fast-expanding global markets of peptide-based pharmaceuticals, cosmetics, and healthcare products. By combining scientific excellence with technological infrastructure, Biomolthera is well-positioned to attract global partnerships, create new investment opportunities, and become a strong competitor on the international stage.
Prof. Dr. Muharrem AKCAN
2011-2013: Post-Doc, Institute for Molecular Bioscience, The University of Queensland, QLD/Australia.
2008-2011: Ph.D. in Biochemistry, Institute for Molecular Bioscience, The University of Queensland, QLD/Australia. Thesis Title: Design and Discovery of Cyclic Peptides with Applications in Drug Development.
2005-2007: M.Sc. in Chemistry, Abant İzzet Baysal University, Graduate School of Sciences, Bolu/Türkiye. Thesis Title: The Ring Closure Reactions of Amidoximes with Phenylboronic Acid.
2000-2004: B.Sc. in Chemistry, Abant İzzet Baysal University, Faculty of Arts and Sciences, Department of Chemistry, Bolu/Türkiye.
